Loading
A phase 2 trial of ensartinib in lung cancer, run by Peking University Cancer Hospital & Institute, not yet recruiting.
Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD is a phase 2, interventional study registered as NCT06780839 by Peking University Cancer Hospital & Institute, with a registry enrolment figure of 70 participants, started 2025-01-15 and due to reach its primary completion in 2029-01-15. Interventions recorded: Ensartinib. Conditions listed: NSCLC, Stage I, II, IIIA, IIIB. Primary outcome: DFS. Lung eligibility wording from the registry: "Histologically confirmed primary non-small cell lung cancer;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Betta Pharmaceuticals, ALK-positive non-small-cell lung cancer, Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Ensartinib, Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Small-molecule kinase inhibitors and the tag lung-deep-dive.
Shares ALK-positive non-small-cell lung cancer, Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares ALK-positive non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Small-molecule kinase inhibitors and the tag lung-deep-dive.
Shares ALK-positive non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares ALK-positive non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Small-molecule kinase inhibitors and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), Small-molecule kinase inhibitors and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.